Nuvo Pharmaceuticals Inc NRIFF

RE: FDA advisers reject Vioxx successor

[ronz]

I would have expected that this news would have given a small boost to our stock price based on another big name drug with a big name pharma behind it, that looks to being kept off yhe market. The FDA stated that they didn't want more drugs,but that they wanted safer drugs........Isn't this what Pennsaid was offering and without all the heart attacks to go with it! This news makes us an even bigger take-over candidate than ever before because the big pharmas are desperate to get a new drug to market for ostioarthritis to help pay off the list of lawsuits that they are facing from their previous drug failures. CHEERS TO ALL WHO CAN UNDERSTAND THAT THERE IS MORE TO THE STORY HERE THAN WHAT WE ARE BEING TOLD!